Post-genomic challenges for collaborative research in infectious diseases

Nature Reviews. Microbiology
Iruka N Okeke, John Wain

Abstract

Although high-burden pathogens have been prioritized for sequencing, genomic research has yet to yield effective vaccines, diagnostics or therapeutics for the infectious diseases that burden developing countries. International research partnerships are needed more today than ever before, and we propose that increased participation by scientists in endemic areas would overcome current roadblocks and is an essential path towards translational research outcomes.

References

Dec 1, 1976·Journal of Autism and Childhood Schizophrenia·J K Darby
Feb 4, 1972·Science·R A Finkelstein, J J LoSpalluto
Sep 30, 1995·BMJ : British Medical Journal·K M De CockE Parry
Dec 20, 2000·Bioinformatics·K RutherfordB Barrell
Aug 22, 2001·The Journal of General Virology·Y P ChanS K Lam
Feb 8, 2002·Nature·Stephen L HoffmanJ Craig Venter
Jun 7, 2002·Nature·D Scott MerrellAndrew Camilli
Oct 2, 2002·Nature Genetics·Abdallah S DaarPeter A Singer
Oct 9, 2002·Nature·Malcolm J GardnerBart Barrell
Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Mar 22, 2003·Lancet·Halla ThorsteinsdóttirPeter A Singer
Oct 1, 1959·Journal of Bacteriology·N K DUTTAD R KULKARNI
Nov 1, 1959·The Journal of Clinical Investigation·R H WATTENR A PHILLIPS
Sep 23, 2003·Social Science & Medicine·Birgit Jentsch, Catherine Pilley
Oct 18, 2003·Science·H VarmusP A Singer
Dec 4, 2003·BMJ : British Medical Journal·J Kay Richmond, Deborah J Baglole
Jan 24, 2004·Lancet·David A SackA K Siddique
Feb 3, 2004·The Journal of Clinical Investigation·William B Greenough
May 15, 2004·Nature Reviews. Genetics·Jay ShendureGeorge M Church
May 29, 2004·Science·Adrian Cho
Dec 14, 2004·Emerging Infectious Diseases·Daniel G BauschBabafemi Oshin
Apr 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shah M FaruqueJohn J Mekalanos
May 27, 2005·Science and Engineering Ethics·Mohsin Raza
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cathy A PettiMerle A Sande
Jan 31, 2006·Lancet·Tikki PangTim Evans
Jun 17, 2006·Science·Béatrice SéguinAbdallah S Daar
Aug 25, 2006·Health Research Policy and Systems·Miguel A González Block

❮ Previous
Next ❯

Citations

Mar 15, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Iruka N OkekeKatarina Nordqvist
Apr 15, 2017·CBE Life Sciences Education·Iruka N OkekeOmolaja R Osoniyi
May 29, 2010·Science·Iruka N Okeke
Mar 10, 2010·Disease Models & Mechanisms·Tiffany Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Ruth BerkelmanKeith Klugman
Respirology : Official Journal of the Asian Pacific Society of Respirology
Guy B MarksWei Xuan
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
J M ChakayaJ Sitienei
© 2022 Meta ULC. All rights reserved